Tenax Historical Balance Sheet

TENX Stock  USD 6.01  0.07  1.18%   
Trend analysis of Tenax Therapeutics balance sheet accounts such as Total Stockholder Equity of 12.7 M, Property Plant And Equipment Net of 0.0, Accounts Payable of 2.2 M or Cash of 9.6 M provides information on Tenax Therapeutics' total assets, liabilities, and equity, which is the actual value of Tenax Therapeutics to its prevalent stockholders. By breaking down trends over time using Tenax Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Tenax Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tenax Therapeutics is a good buy for the upcoming year.

Tenax Therapeutics Inventory

401,964

  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

About Tenax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tenax Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Tenax Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tenax Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tenax currently owns. An asset can also be divided into two categories, current and non-current.

Tenax Therapeutics Balance Sheet Chart

At this time, Tenax Therapeutics' Non Currrent Assets Other are fairly stable compared to the past year. Other Liabilities is likely to rise to about 9.6 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 790.7 K in 2024.

Total Assets

Total assets refers to the total amount of Tenax Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tenax Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tenax Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tenax Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Accounts Payable

An accounting item on the balance sheet that represents Tenax Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Tenax Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Capital Lease Obligations

Tenax Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Tenax Therapeutics asset purchases. For example, Tenax Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Tenax Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.
Most accounts from Tenax Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics' Non Currrent Assets Other are fairly stable compared to the past year. Other Liabilities is likely to rise to about 9.6 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 790.7 K in 2024.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total290.8K807.9K500.9K589.8K
Total Assets6.0M3.4M11.7M15.5M

Tenax Therapeutics balance sheet Correlations

-0.220.190.131.0-0.17-0.990.27-0.140.990.761.00.340.91-0.130.110.891.00.26-0.19-0.19-0.2-0.53-0.390.02-0.31
-0.22-0.04-0.04-0.260.720.280.33-0.03-0.23-0.13-0.25-0.20.17-0.17-0.430.16-0.25-0.22-0.1-0.10.730.090.35-0.160.56
0.19-0.040.830.16-0.2-0.140.05-0.130.140.330.16-0.070.11-0.170.010.380.16-0.17-0.18-0.18-0.18-0.06-0.350.05-0.06
0.13-0.040.830.11-0.29-0.1-0.190.360.10.160.10.30.010.310.250.340.11-0.03-0.33-0.33-0.230.02-0.27-0.160.02
1.0-0.260.160.11-0.2-1.00.25-0.140.990.761.00.340.9-0.120.130.871.00.27-0.18-0.18-0.23-0.53-0.40.03-0.33
-0.170.72-0.2-0.29-0.20.20.46-0.31-0.17-0.07-0.2-0.260.17-0.47-0.560.11-0.2-0.220.140.140.980.030.520.080.6
-0.990.28-0.14-0.1-1.00.2-0.220.1-1.0-0.74-1.0-0.36-0.880.09-0.16-0.85-1.0-0.280.190.190.240.520.39-0.010.34
0.270.330.05-0.190.250.46-0.22-0.530.240.280.23-0.190.47-0.62-0.930.390.23-0.270.60.60.37-0.180.270.670.45
-0.14-0.03-0.130.36-0.14-0.310.1-0.53-0.11-0.38-0.120.74-0.240.820.52-0.11-0.110.05-0.31-0.3-0.220.23-0.05-0.42-0.19
0.99-0.230.140.10.99-0.17-1.00.24-0.110.751.00.350.91-0.10.130.871.00.27-0.19-0.19-0.2-0.53-0.370.01-0.32
0.76-0.130.330.160.76-0.07-0.740.28-0.380.750.75-0.180.71-0.270.00.720.750.16-0.12-0.12-0.14-0.66-0.370.17-0.19
1.0-0.250.160.11.0-0.2-1.00.23-0.121.00.750.340.9-0.120.140.871.00.26-0.21-0.21-0.23-0.53-0.410.0-0.34
0.34-0.2-0.070.30.34-0.26-0.36-0.190.740.35-0.180.340.20.570.340.290.350.21-0.18-0.18-0.20.05-0.14-0.23-0.28
0.910.170.110.010.90.17-0.880.47-0.240.910.710.90.2-0.31-0.140.940.90.12-0.18-0.180.14-0.5-0.250.0-0.06
-0.13-0.17-0.170.31-0.12-0.470.09-0.620.82-0.1-0.27-0.120.57-0.310.62-0.19-0.10.51-0.23-0.22-0.390.150.08-0.31-0.26
0.11-0.430.010.250.13-0.56-0.16-0.930.520.130.00.140.34-0.140.62-0.070.150.37-0.68-0.68-0.48-0.02-0.42-0.67-0.58
0.890.160.380.340.870.11-0.850.39-0.110.870.720.870.290.94-0.19-0.070.870.13-0.27-0.270.09-0.46-0.29-0.04-0.02
1.0-0.250.160.111.0-0.2-1.00.23-0.111.00.751.00.350.9-0.10.150.870.27-0.21-0.21-0.23-0.52-0.41-0.01-0.34
0.26-0.22-0.17-0.030.27-0.22-0.28-0.270.050.270.160.260.210.120.510.370.130.270.040.03-0.23-0.160.270.05-0.36
-0.19-0.1-0.18-0.33-0.180.140.190.6-0.31-0.19-0.12-0.21-0.18-0.18-0.23-0.68-0.27-0.210.041.00.030.060.630.950.06
-0.19-0.1-0.18-0.33-0.180.140.190.6-0.3-0.19-0.12-0.21-0.18-0.18-0.22-0.68-0.27-0.210.031.00.030.060.620.950.06
-0.20.73-0.18-0.23-0.230.980.240.37-0.22-0.2-0.14-0.23-0.20.14-0.39-0.480.09-0.23-0.230.030.030.150.48-0.040.61
-0.530.09-0.060.02-0.530.030.52-0.180.23-0.53-0.66-0.530.05-0.50.15-0.02-0.46-0.52-0.160.060.060.150.22-0.10.14
-0.390.35-0.35-0.27-0.40.520.390.27-0.05-0.37-0.37-0.41-0.14-0.250.08-0.42-0.29-0.410.270.630.620.480.220.480.31
0.02-0.160.05-0.160.030.08-0.010.67-0.420.010.170.0-0.230.0-0.31-0.67-0.04-0.010.050.950.95-0.04-0.10.480.0
-0.310.56-0.060.02-0.330.60.340.45-0.19-0.32-0.19-0.34-0.28-0.06-0.26-0.58-0.02-0.34-0.360.060.060.610.140.310.0
Click cells to compare fundamentals

Tenax Therapeutics Account Relationship Matchups

Tenax Therapeutics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets6.4M6.9M6.0M3.4M11.7M15.5M
Other Current Liab760.0K1.2M597.1K655.7K1.0M790.7K
Total Current Liabilities2.5M2.1M1.6M1.8M3.6M3.8M
Total Stockholder Equity3.8M4.6M4.2M1.5M8.1M12.7M
Property Plant And Equipment Net8.5K176.0K64.8K294.8K186.7K0.0
Net Debt(4.7M)(5.9M)(5.3M)(1.3M)(9.3M)(9.8M)
Retained Earnings(236.2M)(246.0M)(278.5M)(289.5M)(297.3M)(282.4M)
Accounts Payable1.7M757.9K859.6K448.4K2.1M2.2M
Cash4.9M6.3M5.6M2.1M9.8M9.6M
Non Current Assets Total184.4K73.2K303.2K196.2K1.1K1.1K
Cash And Short Term Investments5.4M6.7M5.6M2.1M9.8M10.0M
Common Stock Shares Outstanding309.8K6.5K12.9K18.4K248.4K260.9K
Liabilities And Stockholders Equity6.4M6.9M6.0M3.4M11.7M15.5M
Non Current Liabilities Total749.8K60.4K124.2K183.6K64.2K0.0
Other Current Assets781.0K82.6K105.1K1.1M1.9M2.0M
Other Stockholder Equity239.9M250.6M282.7M291.0M305.4M320.6M
Total Liab2.6M2.2M1.7M1.9M3.6M2.8M
Total Current Assets6.2M6.8M5.7M3.2M11.7M10.5M
Common Stock674.01.3K2.5K4.6K30.028.5
Common Stock Total Equity141.0379.0674.01.3K1.1K1.1K
Property Plant And Equipment Gross8.5K176.0K6.0K294.8K186.7K0.0
Accumulated Other Comprehensive Income(16.2K)516.0458.0(70.0)(63.0)(66.15)
Property Plant Equipment8.5K6.6K64.8K294.8K265.3K172.3K
Net Tangible Assets11.8M3.8M4.6M4.2M3.8M3.6M
Retained Earnings Total Equity(213.5M)(227.8M)(236.2M)(246.0M)(221.4M)(232.5M)
Capital Surpluse222.4M239.6M239.9M250.6M288.2M226.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.